|
|
Volumn 349, Issue 23, 2003, Pages 2188-2190
|
|
Rx: Canadian Drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZODIAZEPINE DERIVATIVE;
CYCLOBENZAPRINE;
DOXYCYCLINE;
INSULIN;
NARCOTIC AGENT;
PROTON PUMP INHIBITOR;
TAMOXIFEN CITRATE;
TRAZODONE;
CANADA;
CONSUMER;
COST BENEFIT ANALYSIS;
DRUG ABUSE;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PRESCRIPTION;
PRIORITY JOURNAL;
REVIEW;
CANADA;
COMMERCE;
COST SAVINGS;
DRUG APPROVAL;
DRUG COSTS;
HUMANS;
LEGISLATION, DRUG;
PRESCRIPTION FEES;
PRESCRIPTIONS, DRUG;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0344874660
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp038196 Document Type: Review |
|
Times cited : (12)
|
|
References (3)
|
